NEO – neogenomics, inc. (US:NASDAQ)

News

Wall Street's Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets [TheStreet.com]
NeoGenomics (NEO) was upgraded by Leerink Partners from "market perform" to "outperform". They now have a $25.00 price target on the stock.
NeoGenomics (NEO) was upgraded by Benchmark Co. from "hold" to "buy".
NeoGenomics (NEO) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
NeoGenomics (NEO) Q1 2026 Earnings Transcript [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com